In addition, the EVs isolated from the serum of lung cancer patients also stimulated NK cells to produce VEGF, CXCL1 and S100A8, which contributed to angiogenesis and immune suppression in the TME (Figure 6e–g). The gene discussed is S100A8; the disease is lung cancer.